Idioma:

CO154 Ramucirumab+Docetaxel Post Immune Checkpoint Inhibitors (ICIS) and Platinum-Based Chemotherapy (CHEMO) in Advanced or Metastatic Non-Small Cell Lung Cancer (ANSCLC): Learnings from the Treat-Lung Observational Study

Pennell, NA ; Clarke, JM ; Liu, S ; Gutierrez, M ; Batus, M ; Bauman, J ; Fidler, MJ ; Marmarelis, ME ; Feliciano, J ; Barzi, A ; Lopes, G ; Molife, C ; Verma, S ; Stefaniak, VJ ; Winfree, KB ; Belli, A ; Cui, Z ; Kim, S ; Manion, C ; Afolabi, M ; Caria, N ; Bonomi, P

Value in health, 2022-07, Vol.25 (7), p.S333 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por

Título:
CO154 Ramucirumab+Docetaxel Post Immune Checkpoint Inhibitors (ICIS) and Platinum-Based Chemotherapy (CHEMO) in Advanced or Metastatic Non-Small Cell Lung Cancer (ANSCLC): Learnings from the Treat-Lung Observational Study
Autor: Pennell, NA ; Clarke, JM ; Liu, S ; Gutierrez, M ; Batus, M ; Bauman, J ; Fidler, MJ ; Marmarelis, ME ; Feliciano, J ; Barzi, A ; Lopes, G ; Molife, C ; Verma, S ; Stefaniak, VJ ; Winfree, KB ; Belli, A ; Cui, Z ; Kim, S ; Manion, C ; Afolabi, M ; Caria, N ; Bonomi, P
É parte de: Value in health, 2022-07, Vol.25 (7), p.S333
Idioma: Inglês

Voltar para lista de resultados